Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2008 09:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest to Present At RBC Capital Markets Healthcare Conference

DANBURY, Conn., Dec. 2, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
November 25, 2008 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Enters Into Second Research and Development Agreement With Otsuka Pharmaceutical

DANBURY, Conn., Nov. 25, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed a second research and development agreement with Otsuka Pharmaceutical...
November 04, 2008 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Reports Third Quarter 2008 Financial Results

DANBURY, Conn., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the third quarter ended September 30, 2008. Overall, as compared to...
October 21, 2008 11:07 ET | Source: Penwest Pharmaceuticals Co.

Penwest Third Quarter 2008 Financial Results Conference Call

DANBURY, Conn., Oct. 21, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Tuesday, November 4th, at 11:00 a.m. EST to review its financial results...
August 05, 2008 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Reports Second Quarter 2008 Financial Results

DANBURY, Conn., Aug. 5, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the second quarter ended June 30, 2008. Overall, as compared to the...
July 23, 2008 08:30 ET | Source: Penwest Pharmaceuticals Co.

Penwest Second Quarter 2008 Financial Results Conference Call

DANBURY, Conn., July 23, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Tuesday, August 5th, at 11:00 a.m. EDT to review its financial results for...
July 22, 2008 11:53 ET | Source: Penwest Pharmaceuticals Co.

Penwest to Present At Two Upcoming Conferences

DANBURY, Conn., July 22, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Ms. Jennifer L. Good, President and Chief Executive Officer, will be presenting at two...
July 14, 2008 08:30 ET | Source: Penwest Pharmaceuticals Co.

Penwest Begins Phase Ia Clinical Trial of A0001, a Compound For Treatment of Mitochondrial Diseases

DANBURY, Conn., July 14, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has begun dosing in a Phase Ia clinical trial of A0001, a compound the Company is...
July 10, 2008 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Begins Phase I Clinical Trial of PW 4153, Candidate For Treatment of Symptoms of Parkinson's Disease

DANBURY, Conn., July 10, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has begun dosing in a Phase I clinical trial of PW 4153, a drug candidate for the...
May 20, 2008 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Enters Into Development and Licensing Agreement With Cobalt Laboratories

DANBURY, Conn., May 20, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed a development and licensing agreement with Cobalt Laboratories Inc. to...